Thermo Fisher Scientific
TMO
2,315 hedge funds and large institutions have $203B invested in Thermo Fisher Scientific in 2022 Q1 according to their latest regulatory filings, with 149 funds opening new positions, 845 increasing their positions, 960 reducing their positions, and 155 closing their positions.
0.63% more ownership
Funds ownership: 87.67% → 88.3% (+0.63%)
4% less first-time investments, than exits
New positions opened: 149 | Existing positions closed: 155
1% less funds holding
Funds holding: 2,343 → 2,315 (-28)
11% less capital invested
Capital invested by funds: $228B → $203B (-$25.2B)
12% less repeat investments, than reductions
Existing positions increased: 845 | Existing positions reduced: 960
16% less funds holding in top 10
Funds holding in top 10: 243 → 205 (-38)
38% less call options, than puts
Call options by funds: $1.02B | Put options by funds: $1.66B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$839M |
| 2 |
Parnassus Investments
San Francisco,
California
|
+$538M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$533M |
| 4 |
NIMI
Natixis Investment Managers International
Paris,
France
|
+$378M |
| 5 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$299M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$460M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$439M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$416M |
| 4 |
BlackRock
New York
|
-$393M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$392M |
TMO Hedge Fund Activity: Q1 2022 in Review
2,315 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2022, worth a combined $203B — down 11% from $228B a quarter earlier.
Sellers outnumbered buyers: 155 funds closed out of TMO and 149 opened new positions — a net loss of 6 holders — while 960 trimmed existing stakes and 845 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $839M. The largest seller was Fidelity Investments, cutting an estimated $460M.
- 2,315 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2022, down from 2,343 in Q4 2021.
- Funds reported $203B of Thermo Fisher Scientific stock for Q1 2022, down 11% quarter-over-quarter.
- 149 funds opened new Thermo Fisher Scientific positions in Q1 2022 and 155 closed out, a net change of -6 holders.
- The largest Thermo Fisher Scientific buyer in Q1 2022 was T. Rowe Price Associates, an estimated $839M added.
- The largest Thermo Fisher Scientific seller in Q1 2022 was Fidelity Investments, an estimated $460M sold.
Based on aggregated 13F filings for Q1 2022.